Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | -23.96% | -.--% | -23.96% |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
02/05 | Capita CFO to Retire in August; Successor Named | MT |
Sales 2024 * | 2.65B 3.34B 279B | Sales 2025 * | 2.79B 3.51B 293B | Capitalization | 238M 299M 25.01B |
---|---|---|---|---|---|
Net income 2024 * | 43M 54.14M 4.52B | Net income 2025 * | 62M 78.06M 6.52B | EV / Sales 2024 * | 0.3 x |
Net Debt 2024 * | 571M 719M 60.07B | Net Debt 2025 * | 533M 670M 56.02B | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
3.6
x | P/E ratio 2025 * |
3.61
x | Employees | 43,000 |
Yield 2024 * |
-
| Yield 2025 * |
2.13% | Free-Float | 95.33% |
Latest transcript on Capita plc
1 day | -23.96% | ||
3 months | -23.96% | ||
6 months | -19.97% | ||
Current year | -23.96% |
Managers | Title | Age | Since |
---|---|---|---|
Adolfo Hernandez
CEO | Chief Executive Officer | - | 31/23/31 |
Tim Weller
DFI | Director of Finance/CFO | 61 | 12/21/12 |
Manpreet Singh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Lowden
CHM | Chairman | 66 | 01/21/01 |
Tim Weller
DFI | Director of Finance/CFO | 61 | 12/21/12 |
Director/Board Member | 59 | 01/22/01 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.11% | 69.78B | |
+6.22% | 17.26B | |
+13.99% | 14.01B | |
+20.42% | 13.52B | |
+15.92% | 9.99B | |
-1.84% | 6.13B | |
+3.03% | 5.25B | |
-1.88% | 4.92B | |
0.00% | 4.87B |
- Stock Market
- Equities
- CPI Stock
- CTAGY Stock